{"id":447831,"title":"Canada Gazette Part I – Biologics, Radio-pharmaceuticals & Genetic Therapies - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T15:22:51.207000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/legislation-guidelines/gazette.html?wbdisable=false","snippet":"Canada Gazette Part I – Biologics, Radio-pharmaceuticals & Genetic Therapies The following proposed regulatory amendments and Regulatory Impact Analysis Statement (RIAS) were recently pre-published in the Canada Gazette Part I for public consultation. Readers are invited to…","rawSnapshotUrl":"/api/snapshots/raw/447831","browseUrl":"https://replay.healtharchive.ca/job-6/20260103152251/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/legislation-guidelines/gazette.html?wbdisable=false#ha_snapshot=447831","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}